Deußing, M.; Buttgereit, L.; Maurer, M.; Swarlik, A.; Stärr, L.; Ohlmann, A.; Kerl-French, K.; Flaig, M.; Sattler, E.C.; French, L.E.;
et al. Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions. Cancers 2025, 17, 151.
https://doi.org/10.3390/cancers17010151
AMA Style
Deußing M, Buttgereit L, Maurer M, Swarlik A, Stärr L, Ohlmann A, Kerl-French K, Flaig M, Sattler EC, French LE,
et al. Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions. Cancers. 2025; 17(1):151.
https://doi.org/10.3390/cancers17010151
Chicago/Turabian Style
Deußing, Maximilian, Lisa Buttgereit, Michaela Maurer, Alisa Swarlik, Lara Stärr, Andreas Ohlmann, Katrin Kerl-French, Michael Flaig, Elke C. Sattler, Lars E. French,
and et al. 2025. "Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions" Cancers 17, no. 1: 151.
https://doi.org/10.3390/cancers17010151
APA Style
Deußing, M., Buttgereit, L., Maurer, M., Swarlik, A., Stärr, L., Ohlmann, A., Kerl-French, K., Flaig, M., Sattler, E. C., French, L. E., & Hartmann, D.
(2025). Benign or Malignant? Ex Vivo Confocal Laser Scanning Microscopy for Bedside Histological Assessment of Melanocytic Lesions. Cancers, 17(1), 151.
https://doi.org/10.3390/cancers17010151
